CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 96 enrolled
Drug / intervention
Remifentanil-Propofol admixturecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04394897
NCT04394897N/ACompleted
CompareCT.gov

Total Intravenous Anesthesia With Remifentanil-propofol Admixture Using Single-infusion Technique

Bezmialem Vakif University·observational·Posted May 20, 2020·Updated May 20, 2020

In Brief

An observational study evaluating Remifentanil-Propofol admixture for Total Intravenous Anesthesia and 3 related conditions. Completed, enrolled 96 participants.

Detailed Summary

Background: Application of total intravenous anesthesia (TIVA) may be considered as unpractical when compared with inhalational anesthesia. Although it is mostly not recommended, mixing intravenous agents seems to be popular in clinical practice. The aim of the study was to investigate the possible clinical drawbacks of using remifentanil-propofol admixture (MIXTIVA) for TIVA.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTotal Intravenous Anesthesia, Propofol, Remifentanil, Bispectral Index Monitoring
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 20, 2020
Enrollment StartMar 12, 2013
Primary CompletionApr 12, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.1 years ago

Interventions

Remifentanil-Propofol admixturecombination